Media ReleaseMarking Immutep’s transition to a Phase III biotech, the Company’s pivotal TACTI-004 trial in first-line non-small cell lung cancer ...

Executives are increasingly fielding analyst questions about the impact of China's DeepSeek AI on their business — and they've got a range of views. Need financial assistance fast? Discover the ...